Trial Details
COMPLETEDBasic Information
| Clinical ID | c1807 |
|---|---|
| Identifier | NCT03980080 |
| Trial Title | Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of OSE-127 in Healthy Subjects |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Healthy Subjects |
| Interventions | DRUG: OSE-127|DRUG: Placebo|DRUG: OSE-127 |
Participant Information
| Sponsor | OSE Immunotherapeutics |
|---|---|
| City | Antwerp |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2018-12-19 |
|---|---|
| Primary Completion Date | 2019-11-04 |
| Completion Date | 2019-11-04 |